PCMA Chief to Lead AdvaMed Accel

AdvaMed has appointed Juan Carlos “J.C.” Scott as chief strategy officer and executive director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening the organization’s role at the innovation ecosystem center.

Scott has extensive experience in healthcare policy, advocacy, and association leadership. He previously served as AdvaMed’s chief advocacy officer and for the last seven years was CEO of the Pharmaceutical Care Management Association (PCMA).

In his new role, Scott will join AdvaMed’s executive leadership team and lead AdvaMed’s Accel division, which represents nearly 500 innovative, early-stage medtech companies. He will focus on deepening AdvaMed’s engagement with emerging and growth-stage medtech companies, investors, strategic partners, and other innovation ecosystem stakeholders while advancing initiatives that strengthen member value and reinforce AdvaMed’s leadership across the medical technology sector.

Working directly with the AdvaMed Accel board of directors, Scott will help expand the organization’s support for entrepreneurs, innovators, and scaling companies, while strengthening relationships across the investment community and broader healthcare ecosystem. 

“J.C. is an accomplished association leader and a respected voice across health care,” AdvaMed President/CEO Scott Whitaker said. “His experience, relationships, and understanding of the innovation ecosystem will help us elevate AdvaMed Accel as the home for emerging medtech companies and investors, and further position AdvaMed as the leading advocate for medical technology innovation.”

Before joining PCMA, Scott served in senior leadership roles at AdvaMed, where he helped advance policy priorities and strengthen the association’s advocacy efforts on behalf of the medical technology industry.

AdvaMed, the Medtech Association, is the world’s largest medical technology association, representing innovators committed to advancing medical technologies that improve patient lives, enhance healthcare outcomes, and drive economic growth.